Home › NDC Lookup › RxCUI directory › RxCUI 2049884

Ivosidenib 250 MG Oral Tablet [Tibsovo] — RxCUI 2049884

RxNorm drug concept · Semantic branded drug
RxCUI 2049884 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2049884
Official nameIvosidenib 250 MG Oral Tablet [Tibsovo]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asTibsovo 250 MG Oral Tablet
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)351 prescriptions · 8 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ivosidenib: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Ivosidenib only works if your cancer cells have a specific change (mutation) in a gene called IDH1. Without that mutation, the drug has no target to work on. The FDA-approved test...
  • Why do I need a genetic test before starting this medicine?
  • Differentiation syndrome happens when cancer cells start maturing and dying off very quickly — the body responds with a kind of inflammatory flood that can affect your lungs, kidne...
  • What is differentiation syndrome, and how will I know if I have it?
📖 Read our full Ivosidenib guide →

🕸️ Concept Web — How Ivosidenib 250 MG Oral Tablet [Tibsovo] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Ivosidenib 250 MG Oral Tablet [Tibsovo] RxCUI 2049884

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Ivosidenib 2049873
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Tibsovo 2049879
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ivosidenib Oral Tablet 2049877
    • Ivosidenib Oral Product 2049875
    • Ivosidenib Pill 2049876
    • Ivosidenib Oral Tablet [Tibsovo] 2049881
    • Tibsovo Oral Product 2049882
    • Tibsovo Pill 2049883
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Ivosidenib 250 MG Oral Tablet SCD · 2049878
  • Ivosidenib 250 MG SCDC · 2049874
  • Ivosidenib Oral Tablet SCDF · 2049877
  • Ivosidenib Oral Product SCDG · 2049875
  • Ivosidenib Pill SCDG · 2049876

Brand-Name Concepts

  • Ivosidenib 250 MG [Tibsovo] SBDC · 2049880
  • Ivosidenib Oral Tablet [Tibsovo] SBDF · 2049881
  • Tibsovo Oral Product SBDG · 2049882
  • Tibsovo Pill SBDG · 2049883
  • Tibsovo BN · 2049879

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 2049884 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
72694-0617-60 1 BOTTLE in 1 CARTON (72694-617-60) / 60 TABLET, FILM COATE... TIBSOVO Servier Pharmaceutical LLC 2021-10-19
Observed labelers: Servier Pharmaceutical LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.